[{"Assets_0_Q1_USD":482232000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1710000.0,"NetIncomeLossConverted_1_Q1_USD":-7011000.0,"RevenuesConverted_1_Q1_USD":49774000.0,"StockholdersEquity_0_Q1_USD":201171000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":11902000.0,"EarningsPerShareBasic_1_Q1_USD":-0.59,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":11902000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.59,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]